(Reuters) -Royal Mail Plc said Britons are having fewer parcels delivered to their homes as pandemic curbs are lifted and it withheld from offering an annual outlook for its UK business due to COVID-19 uncertainties, sending shares down 2% to two-month lows.
Three UK-listed drinks makers and sellers raised their financial targets on Tuesday betting on people stocking their fridges for the summer and soaring demand from bars and restaurants as they reopen after months of pandemic lockdowns.
(Reuters) -Europe's medicines regulator is evaluating an application to use an arthritis drug developed by Sweden's Sobi to treat COVID-19 in adults with pneumonia who are at risk of severe respiratory failure, the agency said on Monday.
Recruitment company SThree on Monday forecast annual earnings ahead of current market estimates after first-half profit more than doubled and said the pandemic was driving more employers to consider adopting a hybrid work model.
Britain's competition regulator has fined more than 10 drug firms a record combined 260 million pounds ($360 million) for overcharging the National Health Service (NHS) for a steroid which rose from 70p to 88 pounds a pack in under eight years.
SSP Chief Executive Simon Smith will step down at the end of 2021 after two years in the role to join a private equity-backed business, the snack food group said on Wednesday, sending its shares to the bottom of Britain's midcap index.
* Sales in most recent week at 42% of 2019 levels
(Adds shares, analyst comment, background)
(Reuters) -Tate & Lyle said on Monday it will sell a controlling stake in its commercial sweeteners unit to a private equity firm in a deal valuing the new standalone business at $1.7 billion including debt as it focuses on healthier food and drinks.